The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis
Open accessAbstract
BACKGROUND: The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. METHODS: In a multicenter, two-by-two factorial trial, we randomly assigned patients with severe sepsis to receive either intensive insulin therapy to maintain euglycemia or conventional insulin therapy and either 10% pentastarch, a low-molecular-weight hydroxyethyl starch (HES 200/0.5), or modified Ringer's lactate for fluid resuscitation. The rate of death at 28 days and the mean score for organ failure were coprimary end points. RESULTS: The trial was stopped early for safety reasons. Among 537 patients who could be evaluated, the mean morning blood glucose level was lower in the intensive-therapy group (112 mg per deciliter [6.2 mmol per liter]) than in the conventional-therapy group (151 mg per deciliter [8.4 mmol per liter], P<0.001). However, at 28 days, there was no significant difference between the two groups in the rate of death or the mean score for organ failure. The rate of severe hypoglycemia (glucose level, < or = 40 mg per deciliter [2.2 mmol per liter]) was higher in the intensive-therapy group than in the conventional-therapy group (17.0% vs. 4.1%, P<0.001), as was the rate of serious adverse events (10.9% vs. 5.2%, P=0.01). HES therapy was associated with higher rates of acute renal failure and renal-replacement therapy than was Ringer's lactate. CONCLUSIONS: The use of intensive insulin therapy placed critically ill patients with sepsis at increased risk for serious adverse events related to hypoglycemia. As used in this study, HES was harmful, and its toxicity increased with accumulating doses. (ClinicalTrials.gov number, NCT00135473.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Though effective, the basal-bolus regimen is labor intensive, requires several injections per day, and is associated with risk of hypoglycemia, affecting up to 10% to 30% of noncritically ill persons.102,1333”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, subsequent studies showed that such aggressive lowering of glycemia in the ICU is not uniformly beneficial, markedly increases the risk of severe hypoglycemia, and may be associated with increased mortality (70–74).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [70]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, subsequent studies showed that such aggressive lowering of glycemia in the ICU is not uniformly beneficial, markedly increases the risk of severe hypoglycemia, and may be associated with increased mortality (70–74).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“However, subsequent studies showed that such aggressive lowering of glycemia in the ICU is not uniformly beneficial, markedly increases the risk of severe hypoglycemia, and may be associated with increased mortality (70–74).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [70]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two randomised controlled trials conducted in critically ill patients in the intensive care unit setting also identified severe hypoglycaemia as an independent risk factor for mortality.25 26”
From The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study (2010) · cites this paper as [25]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [102]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The transition of persons from the hospital to ambulatory or subacute settings is a high-risk period for medication errors, but also an opportunity to improve glycemic control, avoiding what is often termed clinical inertia.102,1285,1286,1380”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [102]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Adipose tissue utilizes 4.5 kcal/kg/day and muscle 13 kcal/kg/day.(352).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [352]
Experimental — accuracy not yet measuredIn the citing paper
“In a single centre study, targeting blood glucose to 80-110 mg/dL reduced ICU mortality [513], however this finding was not reproduced in subsequent multi-centre RCTs [514, 515].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [514]
In the citing paper
“In addition, intensified insulin therapy in critically-ill patients has been shown to be associated with a higher rate of severe hypoglycemic events than less aggressive glycemic control protocols.7–10”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [8]
In the citing paper
“The rate of severe hypoglycemic events (<40 mg/dL) observed in both arms of our trial was significantly lower than those reported in recent international trials of intensive glycemic control.3,4,8”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [8]
In the citing paper
“The overall rate of severe hypoglycemic events in international trials ranged between 5% to 28.6%.3,4,7,8,18,19”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [8]
In the citing paper
“However, subsequent studies showed that such aggressive lowering of glycemia in the ICU is not uniformly bene fi cial, markedly increases the risk of severe hypoglycemia, and may be associated with increased mortality (70 -74).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [70]
In the citing paper
“However, subsequent studies showed that such aggressive lowering of glycemia in the ICU is not uniformly bene fi cial, markedly increases the risk of severe hypoglycemia, and may be associated with increased mortality (70 -74).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [70]
In the citing paper
“However, subsequent studies showed that such aggressive lowering of glycemia in the ICU is not uniformly bene fi cial, markedly increases the risk of severe hypoglycemia, and may be associated with increased mortality (70 -74).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [70]
In the citing paper
“However, in several studies of critically ill medical patients (330,331,333), the incidence of severe hypoglycemia (blood glucose <40 mg/dl) was approximately threefold greater in intensively treated patients.”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [331]
In the citing paper
“In another study using a similar intervention targeting a blood glucose range of 4.4–6.1 mmol in patients admitted with sepsis, no difference in mortality from the conventionally treated group was observed.”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [331]
In the citing paper
“There were more episodes of hypoglycemia, defined as a blood glucose <40 mg/dl (2.2 mmol/l), and more serious adverse events in the group receiving intensive insulin therapy (331).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [331]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
den Berghe, G. V., Wouters, P. J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P., & Lauwers, P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045568.12881.10 · Cited by 1,441
Thadhani, R., Pascual, M. A., & Bonventre, J. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342207 · Cited by 1,426
Colloids versus crystalloids for fluid resuscitation in critically ill patients
Perel, P., Roberts, I., & Ker, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub6 · Cited by 1,154
Moreno, R. P., Vincent, J., Matos, R., de Mendonça, A., Cantraine, F. R. L., THIJS, L. G., Takala, J., Sprung, C. L., Antonelli, M. M., Bruining, H. A., et al. (1999) · Intensive Care Medicine · doi:10.1007/s001340050931 · Cited by 1,050
Flagged first, then by citations
Research works printed but not linked: 3
- Roberts I, 2004, Cochrane Database Syst Rev, 4, CD000567
- Brunkhorst FM, 2005, Infection, 33, 19
- Wiesen P, 2005, Acta Anaesthesiol Belg, 56, 257
Cited by
Sorted by citations
Items 601–700 of 1,002
Intravenous fluid therapy in adult inpatients
Frost, P. (2015) · BMJ · doi:10.1136/bmj.g7620 · Cited by 47
Myers, C. J., Magdesian, K. G., Kass, P. H., Madigan, J. E., Rhodes, D. M., & Marks, S. L. (2008) · The Veterinary Journal · doi:10.1016/j.tvjl.2008.02.024 · Cited by 47
Hyper/hypoglycemia and acute kidney injury in critically ill patients
Fiaccadori, E., Sabatino, A., Morabito, S., Bozzoli, L., Donadio, C., Maggiore, U., & Regolisti, G. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.04.006 · Cited by 47
Hypoglycaemia: current management and controversies
Choudhary, P., & Amiel, S. A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.068197 · Cited by 49
Zarychanski, R., Turgeon, A. F., Fergusson, D. A., Cook, D. J., Hébert, P. C., Bagshaw, S. M., Monsour, D. A., & McIntyre, L. (2009) · PubMed Central · Cited by 47
The Surviving Sepsis Campaign: Where have we been and where are we going?
Dellinger, R. P. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82gr.15001 · Cited by 47
The prevalence of undiagnosed diabetes in non-cardiac surgery patients, an observational study
Abdelmalak, B., Abdelmalak, J. B., Knittel, J. G., Christiansen, E., Mascha, E. J., Zimmerman, R. S., ARGALIOUS, M. Y., & Foss, J. F. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9391-4 · Cited by 47
Extreme Stress Hyperglycemia During Acute Illness in a Pediatric Emergency Department
Weiss, S. L., Alexander, J. L., & Agus, M. S. D. (2010) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181ef0488 · Cited by 47
Ulate, K. P., Falcao, G. C. L., Bielefeld, M. R., Morales, J. M., & Rotta, A. T. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0871 · Cited by 47
Protocols in the management of critical illness
Chang, S. Y., Sevransky, J., & Martin, G. S. (2011) · Critical Care · doi:10.1186/cc10578 · Cited by 52
Thompson, B., Orme, J. F., Zheng, H., Luckett, P. M., Truwit, J. D., Willson, D. F., Hite, R. D., Brower, R. G., Bernard, G. R., Curley, M. A. Q., et al. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200304 · Cited by 47
Safety and efficacy of continuous insulin infusion in noncritical care settings
Smiley, D. D., Rhee, M. K., Peng, L., Roediger, L., Mulligan, P., Satterwhite, L. G., Bowen, P., & Umpierrez, G. E. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.646 · Cited by 46
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
Mendez, C. E., & Umpierrez, G. E. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.180 · Cited by 48
Determination of Organ-Specific Anemia Tolerance*
Lauscher, P., Kertscho, H., Schmidt, O., Zimmermann, R., Rosenberger, P., Zacharowski, K. D., & Meier, J. M. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182746423 · Cited by 46
Verhoeven, J. J., Brand, J. B., van de Polder, M. M., & Joosten, K. (2009) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181ae787b · Cited by 46
Immunomodulatory therapies for sepsis: unexpected effects with macrolides
Giamarellos‐Bourboulis, E. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.004 · Cited by 46
Koch, A. H., Weiskirchen, R., Sanson, E., Zimmermann, H. W., Voigt, S., Dückers, H., Trautwein, C., & Tacke, F. (2010) · Critical Care · doi:10.1186/cc9285 · Cited by 46
An Overview of Preoperative Glucose Evaluation, Management, and Perioperative Impact
Sheehy, A. M., & Gabbay, R. A. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300605 · Cited by 46
Sigrist, N. E., Kälin, N., & Dreyfus, A. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14645 · Cited by 46
Hypertonic saline in critical illness - A systematic review
Pfortmueller, C. A., & Schefold, J. C. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.06.019 · Cited by 46
Once is not enough: clinical trials in sepsis
Sweeney, D. A., Danner, R. L., Eichacker, P. Q., & Natanson, C. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1274-6 · Cited by 46
Self-citationFluid Therapy in Dogs and Cats With Sepsis
Montealegre, F., & Lyons, B. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.622127 · Cited by 49
Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
Sreedharan, R., Khanna, S. K., & Shaw, A. (2023) · Perioperative Medicine · doi:10.1186/s13741-023-00302-6 · Cited by 52
Schierenbeck, F., Öwall, A., Franco‐Cereceda, A., & Liška, J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0169 · Cited by 45
Increasing Blood Glucose Variability Is a Precursor of Sepsis and Mortality in Burned Patients
Pisarchik, A. N., Pochepen, O. N., & Pisarchyk, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046582 · Cited by 45
Glycemic Targets and Approaches to Management of the Patient with Critical Illness
Mesotten, D., & den Berghe, G. V. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0241-8 · Cited by 45
Glycemia Management in Neurocritical Care Patients
Bilotta, F., Giovannini, F., Caramia, R., & Rosa, G. (2008) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e31818f8a5c · Cited by 45
Kim, J. Y., Joung, K.-W., Kim, K., Kim, M.-J., Kim, J. B., Jung, S., Lee, E., & Choi, I. (2015) · Critical Care · doi:10.1186/s13054-015-1065-8 · Cited by 45
Insulin-like Growth Factor-1 Improves Survival in Sepsis via Enhanced Hepatic Bacterial Clearance
Alix, A., Nymon, A. B., Doerschug, K. C., Morrison, J. M., Monick, M. M., & Hunninghake, G. W. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1400oc · Cited by 46
Kalfon, P., Manach, Y. L., Ichaï, C., Bréchot, N., Cinotti, R., Dequin, P., Riu-Poulenc, B., Montravers, P., Annane, D., Dupont, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0851-7 · Cited by 45
Schramko, A. A., Suojaranta-Ylinen, R. T., Niemi, T., Pesonen, E., Kuitunen, A. H., Raivio, P. M., & Salmenperä, M. (2014) · Perfusion · doi:10.1177/0267659114540022 · Cited by 45
Wernly, B., Lichtenauer, M., Hoppe, U. C., & Jung, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.24 · Cited by 47
Anabolic and anticatabolic agents in critical care
Stanojcic, M., Finnerty, C. C., & Jeschke, M. G. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000330 · Cited by 46
Colloids and the Microcirculation
He, H., Liu, D., & İnce, C. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002620 · Cited by 45
Update on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 49
Glycemic control in the intensive care unit: A control systems perspective
Chase, J. G., Benyó, B. I., & Desaive, T. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.03.007 · Cited by 46
on behalf of the TARGET Study Group, Hagel, S., Fiedler, S., Höhn, A., Brinkmann, A., Frey, O. R., Hoyer, H., Schlattmann, P., Kiehntopf, M., Roberts, J. A., et al. (2019) · Trials · doi:10.1186/s13063-019-3437-x · Cited by 48
Self-citationNephroprotective Potential of Human Albumin Infusion: A Narrative Review
Wiedermann, C. J., & Joannidis, M. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/912839 · Cited by 45
Dickerson, R. N., Swiggart, C. E., Morgan, L. M., Maish, G. O., Croce, M. A., Minard, G., & Brown, R. O. (2008) · Nutrition · doi:10.1016/j.nut.2008.02.008 · Cited by 45
Lee, J. S., Ahn, S. W., Song, J. W., Shim, J., Yoo, K., & Kwak, Y. L. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0404 · Cited by 44
Hardy, S. J., Nowacki, A. S., Bertin, M. L., & Weil, R. J. (2010) · Journal of neurosurgery · doi:10.3171/2010.2.jns09950 · Cited by 44
Accuracy of AccuChek glucose measurement in intensive care patients *
Meynaar, I. A., Spreuwel-Verheijen, M. V., Tangkau, P. L., Dawson, L., Visser, S. S., Rijks, L., & Vlieland, T. P. M. V. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a564fe · Cited by 47
Assessment and treatment of hyperglycemia in critically ill patients
Viana, M. V., Moraes, R. B., Fabbrin, A. R., Santos, M. F., & Gerchman, F. (2014) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20140011 · Cited by 49
Reexamining the evidence for inpatient glucose control: New recommendations for glycemic targets
Moghissi, E. S. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100171 · Cited by 45
Serum miR-122 correlates with short-term mortality in sepsis patients
Wang, H., Yu, B., Deng, J., Jin, Y., & Xie, L. (2014) · Critical Care · doi:10.1186/s13054-014-0704-9 · Cited by 44
Strategies to combat chronic critical illness
Maguire, J. M., & Carson, S. S. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328364d65e · Cited by 46
Shohat, N., Foltz, C., Restrepo, C., Goswami, K., Tan, T. L., & Parvizi, J. (2018) · The Bone & Joint Journal · doi:10.1302/0301-620x.100b8.bjj-2017-1283.r1 · Cited by 45
Insulin Therapy in Hospitalized Patients
Pérez, A., Ramos, A., & Carreras, G. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001078 · Cited by 47
Section 3: Prevention and Treatment of AKI
(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.33 · Cited by 45
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients
Iapichino, G., Albicini, M., Umbrello, M., Sacconi, F., Fermo, I., Pavlovich, R., Paroni, R. C., Bellani, G., Mistraletti, G., Cugno, M., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1158-9 · Cited by 44
The Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2117-9 · Cited by 43
Glycemic control in the critically ill: Less is more
Alhatemi, G., Aldiwani, H., Alhatemi, R., Hussein, M., Mahdai, S., & Seyoum, B. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.20171 · Cited by 50
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 45
Hypoglycemia Is Associated With Increased Postburn Morbidity and Mortality in Pediatric Patients*
Jeschke, M. G., Pinto, R. L., Herndon, D. N., Finnerty, C. C., & Kraft, R. (2013) · Critical Care Medicine · doi:10.1097/ccm.0000000000000138 · Cited by 43
Penning, S., Chase, J. G., Preiser, J., Pretty, C. G., Signal, M., Mélot, C., & Desaive, T. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.01.013 · Cited by 43
Hiperglucemia de estrés y su control con insulina en el paciente crítico: evidencia actual
Manzanares, W., & Aramendi, I. (2009) · Medicina Intensiva · doi:10.1016/j.medin.2009.10.003 · Cited by 43
Bardia, A., Khabbaz, K. R., Mueller, A., Mathur, P., Novack, V., Talmor, D. S., & Subramaniam, B. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001715 · Cited by 44
Holbein, M., Béchir, M., Ludwig, S., Sommerfeld, J., Cottini, S. R., Keel, M. J. B., Stocker, R. A., & Stover, J. F. (2009) · Critical Care · doi:10.1186/cc7711 · Cited by 43
de Azevedo, J. R. A., de Araujo, L. O., da Silva, W. S., & de Azevedo, R. P. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.10.011 · Cited by 43
Hoekstra, M., Vogelzang, M., Verbitskiy, E. A., & Nijsten, M. W. (2009) · Critical Care · doi:10.1186/cc8023 · Cited by 45
Ansari, G., Mojtahedzadeh, M., Kajbaf, F., Najafi, A., Khajavi, M. R., Khalili, H., Rouini, M. R., Ahmadi, H., & Abdollahi, M. R. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0075-1 · Cited by 43
Alavi, S. M., Baharvand-Ahmadi, B., Baharestani, B. A., & Babaei, T. (2012) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2012-026 · Cited by 42
Sepsis Pathophysiology and Anesthetic Consideration
Yuki, K., & Murakami, N. (2015) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x15666150108114810 · Cited by 44
Fujishima, S., Gando, S., Saitoh, D., Mayumi, T., Kushimoto, S., Shiraishi, S., Ogura, H., Takuma, K., Kotani, J., Ikeda, H., et al. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.09.003 · Cited by 43
Insulin increases resistance to burn wound infection-associated sepsis
Gauglitz, G. G., Toliver-Kinsky, T. E., Williams, F. N., Song, J., Cui, W., Herndon, D. N., & Jeschke, M. G. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b43236 · Cited by 42
Hartog, C. S., Skupin, H., Natanson, C., Sun, J., & Reinhart, K. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2614-0 · Cited by 43
Self-citationFluid Balance in Patients with Acute Kidney Injury: Emerging Concepts
Godin, M., Bouchard, J., & Mehta, R. L. (2013) · Nephron Clinical Practice · doi:10.1159/000354713 · Cited by 44
Glycemic Control and Organ Transplantation
Marvin, M. R., & Morton-Bailey, V. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300616 · Cited by 42
Wallia, A., Schmidt, K., Oakes, D. J., Pollack, T., Welsh, N., Kling-Colson, S. C., Gupta, S., Fulkerson, C., Aleppo, G., Parikh, N. D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3279 · Cited by 44
Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes
Becker, C. D., Sabang, R. L., Cordeiro, M. F. N., Hassan, I. F., Goldberg, M. D., & Scurlock, C. S. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.012 · Cited by 42
Outcome of Organ Dysfunction in the Perioperative Period
Thiele, R. H., Theodore, D., & Gan, T. J. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005603 · Cited by 42
Matsushima, K., Peng, M., Velasco, C., Schaefer, É., Diaz-Arrastia, R. R., & Frankel, H. L. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.08.012 · Cited by 42
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis
Caraceni, P., Angeli, P., Prati, D., Bernardi, M., Alessandria, C., Riggio, O., Salerno, F., Liumbruno, G. M., Bennardello, F., Piccoli, P., et al. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.008 · Cited by 42
Hanson, J., Lee, S. J., Mohanty, S., Faiz, M. A., Anstey, N. M., Price, R. N., Charunwatthana, P., Yunus, E. B., Mishra, S. K., Tjitra, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087020 · Cited by 41
Fluid Management and Use of Diuretics in Acute Kidney Injury
Nadeau‐Fredette, A., & Bouchard, J. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.09.005 · Cited by 42
Boussekey, N., Darmon, R., Langlois, J., Alfandari, S., Devos, P., Meybeck, A., Chiche, A., Georges, H., & Leroy, O. (2010) · Critical Care · doi:10.1186/cc8920 · Cited by 41
Preissig, C. M., & Rigby, M. R. (2010) · Critical Care · doi:10.1186/cc8865 · Cited by 42
Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes
Dendy, J. A., Chockalingam, V., Tirumalasetty, N. N., Dornelles, A., Blonde, L., Bolton, P. M., Meadows, R. Y., & Andrews, S. S. (2014) · Endocrine Practice · doi:10.4158/ep13467.or · Cited by 41
Ebola virus disease: an update for anesthesiologists and intensivists
Funk, D. J., & Kumar, A. (2014) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-014-0257-z · Cited by 41
Fluid therapy in critical illness
Edwards, M., & Mythen, M. G. (2014) · Extreme Physiology & Medicine · doi:10.1186/2046-7648-3-16 · Cited by 41
Hua, J., Chen, G., Li, H., Fu, S., Zhang, L., Scott, M., & Li, Q. (2012) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2011.12.016 · Cited by 42
Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis
Zuurbier, S. M., Hiltunen, S., Tatlisumak, T., Peters, G. M., Silvis, S. M., Haapaniemi, E., Kruyt, N. D., Putaala, J., & Coutinho, J. M. (2015) · Stroke · doi:10.1161/strokeaha.115.011177 · Cited by 42
Worsley, S. D., Rengerink, K. O., Irving, E. A., Lejeune, S., Mol, K., Collier, S., Groenwold, R. H. H., Enters-Weijnen, C. F., Egger, M., & Rhodes, T. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.05.003 · Cited by 41
Lagny, M.-G., Roediger, L., Koch, J.-N., Dubois, F., Sénard, M., Donneau, A., Hubert, M. B., & Hans, G. A. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.10.010 · Cited by 41
The Management of Severe Sepsis and Septic Shock
Morrell, M. R., Micek, S. T., & Kollef, M. H. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.002 · Cited by 41
Krinsley, J. S., & Fisher, M. C. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.967 · Cited by 42
Green, R. S., Djogovic, D., Gray, S. H., Howes, D. W., Brindley, P. G., Stenstrom, R. J., Patterson, E., Easton, D., & Davidow, J. S. (2008) · Canadian Journal of Emergency Medicine · doi:10.1017/s148180350001054x · Cited by 41
Krinsley, J. S., Bruns, D. E., & Boyd, J. C. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814566507 · Cited by 41
Sabatino, A., Fiaccadori, E., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Cuerda, C., & Bischoff, S. C. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.08.002 · Cited by 40
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?
Schwartz, S. S., & DeFronzo, R. A. (2013) · Diabetes Care · doi:10.2337/dc12-2060 · Cited by 40
Heradstveit, B. E., Guttormsen, A. B., Langørgen, J., Hammersborg, S.-M., Wentzel‐Larsen, T., Fanebust, R., Larsson, E., & Heltne, J.-K. (2010) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/1757-7241-18-29 · Cited by 40
Wiedermann, C. J., & Eisendle, K. (2017) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-016-0090-6 · Cited by 40
Fluid administration and the kidney
Prowle, J. R., & Bellomo, R. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283632e29 · Cited by 42
Management of Sepsis: Early Resuscitation
Rivers, E. P., Coba, V. E., Visbal, A., Whitmill, M. L., & Amponsah, D. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.06.005 · Cited by 41
Hanazaki, K., Kitagawa, H., Yatabe, T., Munekage, M., Dabanaka, K., Takezaki, Y., Tsukamoto, Y., Asano, T., Kinoshita, Y., & Namikawa, T. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.07.048 · Cited by 40
Boldt, J., Brosch, C., Röhm, K. D., Lehmann, A. C., Mengistu, A. M., & Suttner, S. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818370b2 · Cited by 40
RetractedImmunomodulation in Sepsis: State of the Art and Future Perspective
Antonopoulou, A., & Giamarellos‐Bourboulis, E. J. (2010) · Immunotherapy · doi:10.2217/imt.10.82 · Cited by 39
Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
Krinsley, J. S. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1066227 · Cited by 39
van Hooijdonk, R. T. M., Leopold, J. H., Winters, T., Binnekade, J. M., Juffermans, N. P., Horn, J., Fischer, J., van Dongen-Lases, E. C., & Schultz, M. J. (2015) · Critical Care · doi:10.1186/s13054-015-0757-4 · Cited by 39
Bridge over troubled waters: Safe and effective transitions of the inpatient with hyperglycemia
O’Malley, C. W., Emanuele, M., Halasyamani, L. K., & Amin, A. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.355 · Cited by 39
Metadata
- Authors
- Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., Olthoff, D., Jaschinski, U., John, S., Rossaint, R., Welte, T., Schaefer, M., Kern, P., Kuhnt, E., Kiehntopf, M., Hartog, C., Natanson, C., Loeffler, M., & Reinhart, K.
- Affiliations
- Friedrich Schiller University Jena (DE)
- Leipzig University (DE)
- Technische Universität Dresden (DE)
- University Hospital Schleswig-Holstein (DE)
- University of Göttingen (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Martin Luther University Halle-Wittenberg (DE)
- University Hospital Leipzig (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Universitätsklinikum Aachen (DE)
- Medizinische Hochschule Hannover (DE)
- Krankenhaus Dresden-Friedrichstadt (DE)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-01-10
- Volume
- 358
- Issue
- 2
- Pages
- 125-139
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148706741
- Cited by
- 2,921
- References
- 37
- Citations by year
- 2026: 30 · 2025: 47 · 2024: 47 · 2023: 70 · 2022: 68 · 2021: 95 · 2020: 75 · 2019: 85 · 2018: 116 · 2017: 114 · 2016: 158 · 2015: 195 · 2014: 218 · 2013: 245 · 2012: 251
- FWCI
- 265.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Funders
- Massachusetts Medical Society
- Friedrich-Schiller-Universität Jena
- Bundesministerium für Bildung und Forschung (01KI0106)
- Hebrew University of Jerusalem
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- intensive insulin therapy, pentastarch, hydroxyethyl starch, fluid resuscitation, severe sepsis, septic shock, normoglycemia, hypoglycemia, lactated Ringer's solution, acute kidney injury, organ failure, mortality
- MeSH terms
- Ringer's Solution, Aged, Combined Modality Therapy, Dose-Response Relationship, Drug, Female, Fluid Therapy, Humans, Hydroxyethyl Starch Derivatives, Hypoglycemia, Hypoglycemic Agents, Infusions, Intravenous, Insulin, Isotonic Solutions, Male, Middle Aged, Risk Factors, Multivariate Analysis, Critical Illness, Treatment Failure, Sepsis, Kaplan-Meier Estimate, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
